Topiramate is without evidence of efficacy in diabetic neuropathic pain, the only neuropathic condition in which it has been adequately tested. Despite the strong potential for bias, no difference in efficacy between topiramate and placebo was apparent. PubMed, Cochrane Database Syst Rev. 2013 Aug 30. (Also see: Fibromyalgia).
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.